Aconitase Causes Iron Toxicity in Mutants

English version České info

The PTEN-induced kinase 1 (PINK1) is a mitochondrial kinase, and pink1 mutations cause early onset Parkinson's disease (PD) in humans. Loss of pink1 in Drosophila leads to defects in mitochondrial function, and genetic data suggest that another PD-related gene product, Parkin, acts with pink1 to regulate the clearance of dysfunctional mitochondria (mitophagy). Consequently, pink1 mutants show an accumulation of morphologically abnormal mitochondria, but it is unclear if other factors are involved in pink1 function in vivo and contribute to the mitochondrial morphological defects seen in specific cell types in pink1 mutants. To explore the molecular mechanisms of pink1 function, we performed a genetic modifier screen in Drosophila and identified aconitase (acon) as a dominant suppressor of pink1. Acon localizes to mitochondria and harbors a labile iron-sulfur [4Fe-4S] cluster that can scavenge superoxide to release hydrogen peroxide and iron that combine to produce hydroxyl radicals. Using Acon enzymatic mutants, and expression of mitoferritin that scavenges free iron, we show that [4Fe-4S] cluster inactivation, as a result of increased superoxide in pink1 mutants, results in oxidative stress and mitochondrial swelling. We show that [4Fe-4S] inactivation acts downstream of pink1 in a pathway that affects mitochondrial morphology, but acts independently of parkin. Thus our data indicate that superoxide-dependent [4Fe-4S] inactivation defines a potential pathogenic cascade that acts independent of mitophagy and links iron toxicity to mitochondrial failure in a PD–relevant model.

Vyšlo v časopise: Aconitase Causes Iron Toxicity in Mutants. PLoS Genet 9(4): e32767. doi:10.1371/journal.pgen.1003478
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003478

Souhrn

Zdroje

1. DawsonTM, DawsonVL (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302: 819–822.

2. ThomasB, BealMF (2007) Parkinson's disease. Hum Mol Genet 16 Spec No. 2: R183–194.

3. HorowitzMP, GreenamyreJT (2010) Mitochondrial iron metabolism and its role in neurodegeneration. J Alzheimers Dis 20 Suppl 2: S551–568.

4. SoficE, PaulusW, JellingerK, RiedererP, YoudimMB (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem 56: 978–982.

5. LestienneP, NelsonJ, RiedererP, JellingerK, ReichmannH (1990) Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect. J Neurochem 55: 1810–1812.

6. SchapiraAH, CooperJM, DexterD, JennerP, ClarkJB, et al. (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1: 1269.

7. DawsonTM, KoHS, DawsonVL (2010) Genetic animal models of Parkinson's disease. Neuron 66: 646–661.

8. JonesR (2010) The roles of PINK1 and Parkin in Parkinson's disease. PLoS Biol 8: e1000299 doi:10.1371/journal.pbio.1000299.

9. ClarkIE, DodsonMW, JiangC, CaoJH, HuhJR, et al. (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441: 1162–1166.

10. ParkJ, LeeSB, LeeS, KimY, SongS, et al. (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441: 1157–1161.

11. JinSM, YouleRJ (2012) PINK1- and Parkin-mediated mitophagy at a glance. J Cell Sci 125: 795–799.

12. DengH, DodsonMW, HuangH, GuoM (2008) The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc Natl Acad Sci U S A 105: 14503–14508.

13. PooleAC, ThomasRE, AndrewsLA, McBrideHM, WhitworthAJ, et al. (2008) The PINK1/Parkin pathway regulates mitochondrial morphology. Proc Natl Acad Sci U S A 105: 1638–1643.

14. YangY, OuyangY, YangL, BealMF, McQuibbanA, et al. (2008) Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc Natl Acad Sci U S A 105: 7070–7075.

15. NarendraDP, JinSM, TanakaA, SuenDF, GautierCA, et al. (2010) PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8: e1000298 doi:10.1371/journal.pbio.1000298.

16. YangY, GehrkeS, ImaiY, HuangZ, OuyangY, et al. (2006) Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci U S A 103: 10793–10798.

17. GautierCA, KitadaT, ShenJ (2008) Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci U S A 105: 11364–11369.

18. MoraisVA, VerstrekenP, RoethigA, SmetJ, SnellinxA, et al. (2009) Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function. EMBO Mol Med 1: 99–111.

19. VilainS, EspositoG, HaddadD, SchaapO, DobrevaMP, et al. (2012) The yeast complex I equivalent NADH dehydrogenase rescues pink1 mutants. PLoS Genet 8: e1002456 doi:10.1371/journal.pgen.1002456.

20. LiuW, Acin-PerezR, GeghmanKD, ManfrediG, LuB, et al. (2011) Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission. Proc Natl Acad Sci U S A 108: 12920–12924.

21. VosM, EspositoG, EdirisingheJN, VilainS, HaddadDM, et al. (2012) Vitamin K2 is a mitochondrial electron carrier that rescues pink1 deficiency. Science 336: 1306–1310.

22. BeinertH, KennedyMC (1993) Aconitase, a two-faced protein: enzyme and iron regulatory factor. FASEB J 7: 1442–1449.

23. LaubleH, KennedyMC, BeinertH, StoutCD (1992) Crystal structures of aconitase with isocitrate and nitroisocitrate bound. Biochemistry 31: 2735–2748.

24. HiesingerPR, FayyazuddinA, MehtaSQ, RosenmundT, SchulzeKL, et al. (2005) The v-ATPase V0 subunit a1 is required for a late step in synaptic vesicle exocytosis in Drosophila. Cell 121: 607–620.

25. UytterhoevenV, KuenenS, KasprowiczJ, MiskiewiczK, VerstrekenP (2011) Loss of skywalker reveals synaptic endosomes as sorting stations for synaptic vesicle proteins. Cell 145: 117–132.

26. VerstrekenP, OhyamaT, HaueterC, HabetsRL, LinYQ, et al. (2009) Tweek, an evolutionarily conserved protein, is required for synaptic vesicle recycling. Neuron 63: 203–215.

27. FlintDH, TuminelloJF, EmptageMH (1993) The inactivation of Fe-S cluster containing hydro-lyases by superoxide. J Biol Chem 268: 22369–22376.

28. GardnerPR, FridovichI (1991) Superoxide sensitivity of the Escherichia coli 6-phosphogluconate dehydratase. J Biol Chem 266: 1478–1483.

29. GardnerPR, FridovichI (1991) Superoxide sensitivity of the Escherichia coli aconitase. J Biol Chem 266: 19328–19333.

30. Vasquez-VivarJ, KalyanaramanB, KennedyMC (2000) Mitochondrial aconitase is a source of hydroxyl radical. An electron spin resonance investigation. J Biol Chem 275: 14064–14069.

31. BenovL, SztejnbergL, FridovichI (1998) Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radic Biol Med 25: 826–831.

32. HorakP, CrawfordAR, VadysirisackDD, NashZM, DeYoungMP, et al. (2010) Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis. Proc Natl Acad Sci U S A 107: 4675–4680.

33. WangYC, LeeCM, LeeLC, TungLC, Hsieh-LiHM, et al. (2011) Mitochondrial dysfunction and oxidative stress contribute to the pathogenesis of spinocerebellar ataxia type 12 (SCA12). J Biol Chem 286: 21742–21754.

34. PetratF, WeisheitD, LensenM, de GrootH, SustmannR, et al. (2002) Selective determination of mitochondrial chelatable iron in viable cells with a new fluorescent sensor. Biochem J 362: 137–147.

35. PhilpottCC, KlausnerRD, RouaultTA (1994) The bifunctional iron-responsive element binding protein/cytosolic aconitase: the role of active-site residues in ligand binding and regulation. Proc Natl Acad Sci U S A 91: 7321–7325.

36. MissirlisF, HolmbergS, GeorgievaT, DunkovBC, RouaultTA, et al. (2006) Characterization of mitochondrial ferritin in Drosophila. Proc Natl Acad Sci U S A 103: 5893–5898.

37. GeislerS, HolmstromKM, SkujatD, FieselFC, RothfussOC, et al. (2010) PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12: 119–131.

38. GeislerS, HolmstromKM, TreisA, SkujatD, WeberSS, et al. (2010) The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations. Autophagy 6: 871–878.

39. KohH, ChungJ (2012) PINK1 as a molecular checkpoint in the maintenance of mitochondrial function and integrity. Mol Cells 34: 7–13.

40. YuW, SunY, GuoS, LuB (2011) The PINK1/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons. Hum Mol Genet 20: 3227–3240.

41. ImaiY, LuB (2012) Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorder. Curr Opin Neurobiol 21: 935–941.

42. TwigG, ShirihaiOS (2011) The interplay between mitochondrial dynamics and mitophagy. Antioxid Redox Signal 14: 1939–1951.

43. CantuD, SchaackJ, PatelM (2009) Oxidative inactivation of mitochondrial aconitase results in iron and H2O2-mediated neurotoxicity in rat primary mesencephalic cultures. PLoS ONE 4: e7095 doi:10.1371/journal.pone.0007095.

44. LiochevSI, FridovichI (1994) The role of O2.- in the production of HO.: in vitro and in vivo. Free Radic Biol Med 16: 29–33.

45. SakuraiK, StoyanovskyDA, FujimotoY, CederbaumAI (2000) Mitochondrial permeability transition induced by 1-hydroxyethyl radical. Free Radic Biol Med 28: 273–280.

46. SrivastavaS, ChanC (2007) Hydrogen peroxide and hydroxyl radicals mediate palmitate-induced cytotoxicity to hepatoma cells: relation to mitochondrial permeability transition. Free Radic Res 41: 38–49.

47. VercesiAE, KowaltowskiAJ, GrijalbaMT, MeinickeAR, CastilhoRF (1997) The role of reactive oxygen species in mitochondrial permeability transition. Biosci Rep 17: 43–52.

48. PitkanenS, RobinsonBH (1996) Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J Clin Invest 98: 345–351.

49. TurrensJF (1997) Superoxide production by the mitochondrial respiratory chain. Biosci Rep 17: 3–8.

50. BetarbetR, ShererTB, MacKenzieG, Garcia-OsunaM, PanovAV, et al. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3: 1301–1306.

51. CannonJR, TapiasV, NaHM, HonickAS, DroletRE, et al. (2009) A highly reproducible rotenone model of Parkinson's disease. Neurobiol Dis 34: 279–290.

52. CoulomH, BirmanS (2004) Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster. J Neurosci 24: 10993–10998.

53. DauerW, PrzedborskiS (2003) Parkinson's disease: mechanisms and models. Neuron 39: 889–909.

54. KohH, KimH, KimMJ, ParkJ, LeeHJ, et al. (2012) Silent information regulator 2 (Sir2) and Forkhead box O (FOXO) complement mitochondrial dysfunction and dopaminergic neuron loss in Drosophila PTEN-induced kinase 1 (PINK1) null mutant. J Biol Chem 287: 12750–12758.

55. BermanSB, HastingsTG (1999) Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J Neurochem 73: 1127–1137.

56. ZhangF, DryhurstG (1994) Effects of L-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic Parkinson's disease. J Med Chem 37: 1084–1098.

57. ZoccaratoF, ToscanoP, AlexandreA (2005) Dopamine-derived dopaminochrome promotes H(2)O(2) release at mitochondrial complex I: stimulation by rotenone, control by Ca(2+), and relevance to Parkinson disease. J Biol Chem 280: 15587–15594.

58. SnyderAM, ConnorJR (2009) Iron, the substantia nigra and related neurological disorders. Biochim Biophys Acta 1790: 606–614.

59. ChaGH, KimS, ParkJ, LeeE, KimM, et al. (2005) Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. Proc Natl Acad Sci U S A 102: 10345–10350.

60. PesahY, PhamT, BurgessH, MiddlebrooksB, VerstrekenP, et al. (2004) Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development 131: 2183–2194.

61. VerstrekenP, LyCV, VenkenKJ, KohTW, ZhouY, et al. (2005) Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron 47: 365–378.

62. DietzlG, ChenD, SchnorrerF, SuKC, BarinovaY, et al. (2007) A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature 448: 151–156.

63. BischofJ, MaedaRK, HedigerM, KarchF, BaslerK (2007) An optimized transgenesis system for Drosophila using germ-line-specific phiC31 integrases. Proc Natl Acad Sci U S A 104: 3312–3317.

64. VenkenKJ, HeY, HoskinsRA, BellenHJ (2006) P[acman]: a BAC transgenic platform for targeted insertion of large DNA fragments in D. melanogaster. Science 314: 1747–1751.

65. WuJS, LuoL (2006) A protocol for dissecting Drosophila melanogaster brains for live imaging or immunostaining. Nat Protoc 1: 2110–2115.